Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sotera Health (SHC) EBITDA: 2019-2024

Historic EBITDA for Sotera Health (SHC) over the last 6 years, with Dec 2024 value amounting to -$71.2 million.

  • Sotera Health's EBITDA fell 17.46% to $31.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.5 million, marking a year-over-year decrease of 9.52%. This contributed to the annual value of -$71.2 million for FY2024, which is 208.91% down from last year.
  • Sotera Health's EBITDA amounted to -$71.2 million in FY2024, which was down 208.91% from $65.3 million recorded in FY2023.
  • Sotera Health's 5-year EBITDA high stood at $127.7 million for FY2021, and its period low was -$256.7 million during FY2022.
  • In the last 3 years, Sotera Health's EBITDA had a median value of -$71.2 million in 2024 and averaged -$87.5 million.
  • Its EBITDA has fluctuated over the past 5 years, first crashed by 621.06% in 2020, then spiked by 435.40% in 2021.
  • Sotera Health's EBITDA (Yearly) stood at -$38.1 million in 2020, then soared by 435.40% to $127.7 million in 2021, then tumbled by 301.00% to -$256.7 million in 2022, then spiked by 125.46% to $65.3 million in 2023, then tumbled by 208.91% to -$71.2 million in 2024.